🇺🇸 FDA
Patent

US 7192982

Modulators of peroxisome proliferator activated receptors

granted A61PA61P1/14A61P15/00

Quick answer

US patent 7192982 (Modulators of peroxisome proliferator activated receptors) held by Ligand Pharmaceuticals Incorporated expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/14, A61P15/00, A61P3/00, A61P3/04